South Africa approves Pfizer vaccine booster amid COVID wave
ABC News
South Africa’s regulatory authority has approved the Pfizer-BioNTech vaccine as a booster shot, opening the way for third doses to be administered to battle the current surge driven by the omicron variant
JOHANNESBURG -- South Africa’s regulatory authority has approved the Pfizer-BioNTech vaccine as a booster shot, opening the way for third doses to be administered to battle the current surge driven by the omicron variant.
South Africa’s new COVID-19 cases continue to rise. In the last 24 hours, South Africa recorded 22,391 new cases, up from about 200 per day in early November. More than 90% of the new cases are omicron, according to genetic sequencing surveys.
The South African Health Products Regulatory Authority approved the Pfizer vaccine as a booster shot for people 18 years and older, six months after they received their second dose.
The regulatory body also approved a third dose for people aged 12 years and older who were “severely immunocompromised,” which may be taken 28 days after their second dose.
